WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: A330350)
Health Care · Pharmaceuticals · KR
₩7,040.00
-2.90% today · +2.0% 1Y
WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: A330350) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $69.12M.
Over the last twelve months the share price has gained 2.0%, trading between 5.91K and 11.95K.
Tweenvest scores WITHUS PHARMACEUTICAL Co.,LTD. across four factors: quality 73/100, value 73/100, growth 31/100. Its strongest factor is quality.
A330350 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $69.12M
- Revenue (TTM)
- $72.14M
- P/E
- 11.67
- EPS
- 603.28
- Dividend yield
- —
- Beta (5Y)
- 0.68
- 52-week high
- ₩11,950.00
- 52-week low
- ₩5,910.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.20M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| DongKoo Bio & Pharma Co., Ltd.KOSDAQ: A006620 | $70.70M | ₩3,515.00 | -0.14% |
| Verrica Pharmaceuticals Inc.NasdaqCM: VRCA | $70.60M | $4.08 | -0.73% |
| Poolbeg Pharma PLCAIM: POLB | $69.71M | £0.07 | -3.90% |
| KOREA PHARMA Co., Ltd.KOSDAQ: A032300 | $69.53M | ₩8,570.00 | -1.72% |
| NeOnc Technologies Holdings, Inc.NasdaqGM: NTHI | $69.10M | $2.90 | +4.32% |
| Syngen Biotech Co.,Ltd.TPEX: 8279 | $68.57M | NT$80.90 | +1.76% |
| Y.S.P. Southeast Asia Holding BerhadKLSE: YSPSAH | $68.04M | RM1.96 | +1.55% |
| Valiant Laboratories LimitedNSEI: VALIANTLAB | $67.23M | Rs119.80 | -4.22% |
Figures last refreshed Oct 11, 2026.